Acute Coronary Syndrome

As people around the country struggle to catch up on sleep after “springing forward” an hour, a Washington Post story reminds us of the health risks associated with adjusting our clocks, including an increased incidence of heart attacks.

Both initial and serial increases in high-sensitivity C-reactive protein (hsCRP) concentrations are independently predictive of cardiac events following acute coronary syndrome (ACS), according to a new study in JAMA Cardiology.

The proportion of heart attack patients who are 40 or younger has steadily increased over the last decade, according to research set to be presented March 17 at the American College of Cardiology’s scientific sessions in New Orleans.

Women are more likely to call ambulances for male relatives like brothers, sons and husbands with suspected MIs than they are to call an ambulance for themselves, according to research presented March 3 at the European Society of Cardiology’s Acute Cardiovascular Care 2019 congress in Malaga, Spain.

Delay to hospital presentation and suboptimal post-percutaneous coronary intervention (PCI) TIMI flow grades are both independently associated with excess mortality in women who suffer ST-segment elevation myocardial infarction (STEMI), according to a study that sought to better define the disproportionate sex gap in STEMI mortality.

The addition of rivaroxaban to aspirin monotherapy reduces the risk of atherothrombotic events in patients who have experienced an acute coronary syndrome (ACS), but it can also increase those patients’ bleeding risk, according to a study published Feb. 28 in the Journal of the American Heart Association.

A systematic approach to transitioning heart attack patients from the hospital to outpatient care helped the Sanger Heart & Vascular Institute in Charlotte, North Carolina, drop its 30-day readmission and death rates while increasing the likelihood of patients making and keeping follow-up appointments.

ACC.19 will feature 36 late-breaking clinical trials and clinical research studies, starting with the Apple Heart Study’s findings on the ability of a smartwatch to help identify atrial fibrillation. That question is just one of many the conference will address, says ACC.19 Program Chair Andrew Kates, MD, professor of medicine and director of the cardiology fellowship program at Washington University School of Medicine in St. Louis. During a conversation with Cardiovascular Business, Kates predicted trial highlights and previewed some ACC.19 program innovations. 

Patients with coronary artery disease (CAD) enrolled in private insurance plans through Medicare Advantage (MA) are more likely to receive guideline-recommended medications for secondary prevention than those in fee-for-service Medicare, according to a new analysis in JAMA Cardiology. But that wasn't tied to improvements in blood pressure or cholesterol levels.

Transgender men and women might face an increased risk of cardiovascular ills like MI, stroke and venous thromboembolic events (VTEs) as a result of hormone replacement therapy—an often key aspect of the transitioning process for trans individuals.

An elevated heart rate upon hospital admission has been repeatedly linked to an increased risk of mortality for acute MI patients (AMI), making admission heart rate a key component of risk-stratification equations. But researchers recently found a patient’s heart rate at discharge was an even more powerful predictor of death over three years of follow-up.

High-risk strains of human papillomavirus (HPV)—ones that have been linked to anogenital and oral cancers—might also increase a woman’s risk for developing cardiovascular disease, research out of Seoul, South Korea, suggests.